Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Haopeng Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3077-5507; OpenAlex author ID A5035725902. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 2 papers · 2024: 1 paper

Papers 3

  1. Piezo1 Mediates Glycolysis-Boosted Pancreatic Ductal Adenocarcinoma Chemoresistance within a Biomimetic Three-Dimensional Matrix Stiffness. Co-author DOI 10.1021/acsbiomaterials.4c01319↗
  2. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy. Co-author DOI 10.1021/acsbiomaterials.3c00487↗
  3. Matrix stiffness triggers chemoresistance through elevated autophagy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1039/d3bm00598d↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yibing Guo · 3 shared papers, 2023–2024 · strength 0.56
  2. Di Wu · 3 shared papers, 2023–2024 · strength 0.56
  3. Jiashuai Yan · 2 shared papers, 2023–2024 · strength 0.38
  4. Tiancheng Gong · 2 shared papers, 2023 · strength 0.35
  5. Biwen Zhu · 1 shared paper, 2024 · strength 0.20
  6. Xiaoqi Guan · 1 shared paper, 2024 · strength 0.20
  7. Xue Zhang · 1 shared paper, 2024 · strength 0.20
  8. Xihao Yao · 1 shared paper, 2023 · strength 0.18
  9. Xiaohong Li · 1 shared paper, 2023 · strength 0.18
  10. Yuhua Lu · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.